¡¸ ºô¸ô¤º¬ìÄ~Äò±Ð¨| ¡¸
¦³®Ä´Á¶¡¡G¥Á°ê 101¦~10¤ë01¤é ¦Ü 101¦~10¤ë31¤é ¤î

    Case Discussion
< Report of a Case>

¡@¡@A 77-year-old male patient, with a 10-year history of diabetes mellitus, was admitted because of acute onset of fever, chills, diarrhea and non-productive cough after returning from a cruise tour 4 days later. He was admitted to the emergency service at this hospital because of altered mental status. At the emergency service, the temperature was 39.5°C, the blood pressure 116/58 mmHg, the pulse rate 128 beats per minute, and the respiration rate 36 breaths per minute. Chest auscultation revealed crackles at the right upper and left lower lung fields. There were no lymphadenopathies, skin rashes, throat exudates, cardiac murmurs, peritoneal signs or legs edema. Neurological examination revealed that he was poorly oriented to persons, place, and time. There was no neck stiffness, meningeal signs, or focal neurological signs. The tendon reflex was normal. Lumbar puncture was performed and the results did not show pleocytosis. He was admitted to the intensive care unit for acute respiratory distress and confusion status. Endotracheal intubation was performed.

¡@¡@His family reported that the diabetes mellitus had been well controlled with diet and metformin. He was a retired senior high school teacher and had a habit of smoking for several decades. There was no history of recent operation, hospitalization, animal contact or family clustering of similar cases.

The results of laboratory studies were as follows.

1. CBC and differential count:
WBC
/£gl

RBC
M/£gl

Hb
g/dl

Plt
K/£gl

Hct
%

MCV
fL

Band
%

Neutro
%

Baso
%

Eos
%

Mon
%

Lym
%

17300

4.07

15.4

178

41.4

89.4

6

78

1

2

3

10

2. Biochemistry:
A/G
g/dl

ALP
U/L

AST
U/L

ALT
U/L

r-GT
U/L

BUN
mg/dL

Cre
mg/dL

Na
mmol/L

K
mmol/L

Cl
mmol/L

3.7/3.4

225

87

124

45

54.8

1.73

125

4.3

102

Ca
mmol/L

P
mmol/L

Mg
mmol/L

Glu
mg/dL

LDH
U/L

TG
mg/dL

T-CHO
mg/dL

UA
mg/dL

BilT/D mg/dL

2.02

3.5

0.94

139

463

174

223

7.6

1.4/0.8

3. ABG (non-rebreather mask, FiO2 100%)
pH

PCO2
(mmHg)

PO2
(mmHg)

HCO3-
(mEq/L)

B.E
(mEq/L)

7.41

18

72.9

11.3

-11.0

4. Sputum routine
Microscopy of an expectorated sputum specimen disclosed PMNs, 50-75/low power fields (LPF), few epithelial cells (<10/LPF), and no pathogens by Gram's stain.

5. CSF study
Open Pressure
(mmH2O)

WBC

Lymphocyte

Neutrophil

Glucose
(mg/dL)

Protein
(mg/dL)

101

4

4

0

58

40

6. Chest X ray
CXR revealed alveolar infiltrates in the left lower and right upper lobes.

< »¡©ú>

¡@ °h¥î­x¤H¯g¬O¥Ñ°h¥î­x¤H±ìµß(Legionella)¤Þ°_ªº¶Ç¬V¯f¡C¦¹¯f¦W¥Ñ¨Ó¡A·½©ó1976¦~¦b¬ü°ê¥l¶}ªº°h¥î­x¤H¤j·|®É¡A°h¥î­x¤H±ìµß´¿¤Þ­PªÍª¢Ãzµo¦Ó©R¦W¡C°h¥î­x¤H±ìµß¥i¦b¦hºØªºÀô¹Ò¤¤¦s¦b¡A¤×¨ä¾A¦X¦bÄá¤ó20 ¡V 45«×ªº·Å¤ô¤¤¥Íªø¡C¥¦¥i¦s¬¡¦b¤£¦Pªº¤ô·½Àô¹ÒùØ¡A¦p¤ô¬û¡B§N¼ö¤ô¨t²Î¡B§N«o¤ô¶ð¡B«ö¼¯¦À¡B¼Q¤ô¦À©M®a©~©I§l¹DÂåÀø¾¹§÷µ¥¡C°h¥î­x¤Hµß¥i©óÀô¹Ò¤¤(¥]¬A¡G¤ô¤Îªd¤g)¦s¬¡¼Æ­Ó¤ë¡A¥B¯à«ùÄòºû«ù¨ä­P¯f©Ê¡F¨ä¤¤¤ôÀô¹Ò¬O°h¥î­x¤Hµß¤ÑµM¥Íªø³B¡A¤]¬O·P¬Vªº¥D­n¨Ó·½¡F¨ä¶Ç¼½³~®|«h¥H­¸ªj(droplet)ª½±µ§l¤J¬°¥D¡A¤×¨ä¸g¥Ñ¼QÃúª¬¤§¤ô®ð(aerosol)¡A¨ä¨Ó·½¥]¬A¡G§N«o¤ô¶ð¡B©I§lªvÀø¾¹±ñ¡B²O¯Dµ¥¡C¦¹¥~¡A¶Ë¤fª½±µ±µÄ²¦Ã¬V¤§¤ô¡A¥ç·|³y¦¨·P¬V¡C°h¥î­x¤H¯g¨Ã¤£·|³z¹L¤H»P¤H¤§¶¡ªº±µÄ²¦Ó¶Ç¼½¡C°h¥î­x¤H¯g¤j³¡¤Àµo¥Í©ó§K¬Ì¾÷¯à²§±`¤§¯f¤H¡A¥]¬A¡G¦~ªøªÌ(50·³¥H¤W)¡B¨ã¦³ÄY­«¼ç¦b¯e¯f¦p¿}§¿¯f¡BºC©Ê¤ßªÍ¯e¯f¡B©âµÒ¡B°sÅ}¡B±µ¨ü¾¹©x²¾´Ó¤Î¨Ï¥Î§K¬Ì§í¨îÃĪ«µ¥¯f±w¡C«D¨å«¬ªÍª¢¬°°h¥î­x¤H¯g¥D­n¤§Á{§Éªí²{¡A¦Ó¯f¤H¤§¯gª¬®t²§·¥¤j¡A±q»´·L«y¹Â¡Bµo¿N¦Ü©I§l°IºÜ¡B¦h¾¹©x°IºÜµ¥¡C¼ç¥ñ´Á¬ù2¦Ü10¤Ñ¡C¥D­n¯f¼x¥]¬Aµo¿N¡B°®«y¡B©I§l§xÃø¡B¯h­Â¡BÀYµh¡B¦Ù¦×¯kµh¡B¸¡µh©M¸¡Âm¡C¯f±¡ÄY­«®É¥i¥X²{¯«¸g¨t²Î¯f¼x¡]¦pºë¯«¿ù¶Ã¡^©M©I§l°IºÜ¡A¨Ã¤Þ­P¦º¤`¡C¦b¯e¯f¦­´Á¡A¯f¤H±`ªí²{¥X¤@¨Ç«D¯S²§©Ê¤§¯gª¬¡A¥]¬A¡Gµo¿N(±`°ª©óÄá¤ó40«×)¡B¯h­Â¡B¦Ù¦×¯kµh¡BÀYµhµ¥¡C¯f¤H³q±`ªí²{°®«y¡B¬Û¹ï©Ê¤ß·i¹LºC¡B¸¡Âm¡B¯«´¼¤£²Mµ¥¡F³¡¥÷¨ü°h¥î­x¤H±ìµß·P¬Vªº±wªÌ¡A¥i¯à¥u·|¥X²{µu¼È©M¦Û¦æ´î°hªºµo¼ö¯f¼x¡A³oÃþ«DªÍª¢©Êªº±¡ªpºÙ¬°¡uÃe¸¦¨È§J¼ö¡v¡] Pontiac fever ¡^¡C¹êÅç«Ç±`³WÀˬd¥H§C¶u¦å¯g¤Î¨x¥\¯à²§±`¬°°h¥î­x¤H¯g³Ì±`¨£¤§ÀËÅ粧±`±¡§Î¡C¯Ý³¡¢æ¥ú¨ÃµL¯S²§©Êªºªí²{¡A¥i¥H¬O§½³¡©Ê®û¼í¡B¸~½F¼Ë¡Bµ²¸`ª¬¡B³æ©ÎÂù°¼©Ê«I¥Ç¡B¶}¬}¬Æ¦Ü¦Ø½¤¿n¤ôµ¥¡A¤£©ö¥Ñ¯Ý³¡¢æ¥ú¨ÓÆJ¤U¶EÂ_¡C°h¥î­x¤H±ìµß¤£©ö¬V¦â¡A¬°­²Äõ¤ó¬V¦â³±©Ê±ìµß¡A°h¥î­x¤Hµß°ö¾i»Ý­n¯S®íªº°ö¾i¥×¡A°ö¾i®É»Ý­n¥b¯ÖÓi»Ä¡] cysteine ¡^¤Î¨ä¥LÀç¾i¯À¡C¦]¦¹¤£©ö°õ¦æ¡C¦å²M¾Ç¤Î§¿²G¤§§Ü­ì§ÜÅéÀˬd¸g±`¨Ï¥Î¨Ó½T©w¶EÂ_¡C¨ì¥Ø«e¬°¤î¦@µo²{ 14 ºØ¶ÝªÍ©Ê°h¥î­x¤H±ìµß¡] Legionella pneumophila ¡^ªº¦å²M«¬¡A¨ä¤¤¥H¦å²M«¬²Ä¤@«¬³Ì±`¤Þ°_°h¥î­x¤H¯f¡C¹êÅç«Ç½T©w¶EÂ_¥]¬A¡G(1)¥ÑªÍ²Õ´¡B©I§l¹D¤Àªcª«¡B¯Ý½¤²G¡B¦å²G©Î¨ä¥L¥¿±`µLµßªº³¡¦ì¡A¤ÀÂ÷¥X°h¥î­x¤H±ìµß¡C(2)ª½±µ§K¬Ì¿Ã¥ú§ÜÅé¸ÕÅç¡A¦bªÍ²Õ´¡B©I§l¹D¤Àªcª«©Î¯Ý½¤²GÀËÅç¥X¶ÝªÍ©Ê°h¥î­x¤H±ìµß¡]L. pneumophila¡^¡C(3)¥H¶¡±µ§K¬Ì¿Ã¥ú§ÜÅé¸ÕÅçÀË´ú¦å²M§ÜÅé®Ä»ù¡A«ì´_´Á¡]4¦Ü12¶g¡^¤ñµo¯fªì´Á®Ä»ù¦³¥|­¿¥H¤W¼W¥[¡A¥B¡Ù128­¿¡C(4)¥H»Ã¯À³sµ²§K¬Ì¤ÀªRªk©Î©ñ®g§K¬Ì¤ÀªRªkÀËÅç¥X§¿¤¤¦³¶ÝªÍ©Ê°h¥î­x¤H±ìµß¦å²M«¬²Ä¤@«¬¡] L. pneumophila serogroup ¢¹¡^¤§§Ü­ì¡C°h¥î­x¤H¯f±wªÌ¤§¦º¤`²v¥i°ª¹F 15 ¢H¡AªvÀø©µ»~©¹©¹¤j¤j¦a¼W¥[¨ä¦º¤`²v¡A¤×¨ä¹ï©ó¿©±wÄY­«¤§ªÀ°Ï©Ê©Î°|¤ºªÍª¢¡A¨ä¦º¤`²v§ó¥i°ª¹F80¢H¡A©Ò¥HÁ{§ÉÂå®v°È¥²±N¦¹¯f¦C¤J¦Ò¼{¨Ãµ¹¤©¸gÅçÀøªk¡C±`¥ÎªvÀøÃĪ«¥]¬A¬õÅð¯ÀÃþ(macrolides)¡B(¤f«¶)¿Õà¬Ãþ(fluoroquinolones)¡B¥|ÀôÅð¯ÀÃþ(tetracyclines)¡BÁDÓiÃþ(trimethoprim/sulfamethoxazole)µ¥¡C¹w¨¾°h¥î­x¤H¯g¤§¹w¨¾¡A¥]¬A¡G±N¤ô¥[¼ö¦ÜÄá¤ó70-80«×¡B¸m©ñ»É»ÈÂ÷¤l¤Æ¾¹±ñ¡B¥[´â®ø¬rµ¥¡A©w´Á²M¬~¤ô¶ð¤@¦~¦Ü¤Ö¨â¦¸¡C¥Ø«e¨Ã¨S¦³¹w¨¾°h¥î­x¤H¯gªº¬Ì­]¡C

< °Ñ¦Ò¸ê®Æ >

  1. ½Ã¥Í¸p¯e¯fºÞ¨î§½¡G¶Ç¬V¯f¤¶²Ð - °h¥î­x¤H¯g¡Chttp://www.cdc.gov.tw/professional/disease.aspx?treeid=beac9c103df952c4&nowtreeid=6b7f57aafde15f54. (accessed on July 31, 2012)
  2. Longo DL, Fauci AS, Kasper DL, et al. (eds). Chapter 147. Legionella Infections. Harrison's Online Harrison's Principles of Internal Medicine, 18th edition. 2012
  3. van Duin D. Diagnostic challenges and opportunities in older adults with infectious diseases. Clin Infect Dis. 2012;54(7):973-8.
  4. Carratala J, Garcia-Vidal C. An update on Legionella. Curr Opin Infect Dis 2010;23(2):152-7.
  5. Stout JE, Yu VL. Legionellosis. N Engl J Med 1997;337(10):682-7.

Ä~Äò±Ð¨|¦ÒÃD
1.
(C)
Which is the most possible causative pathogen for this patient with severe community-acquired pneumonia?
A Streptococcus pneumoniae
BHaemophilus influenzae
CLegionella pneumophila
DStaphylococcus aureus
2.
(C)
Which of the following investigations is most helpful in identifying the etiology of pneumonia in this case?
ASputum acid-fast stain
B Blood culture
CUrinary antigen test
DNasal swab for isolation
3.
(A)
Which of the following is not a risk factor of acquiring the causative pathogen in this case?
ANo previous pneumococcal vaccination
BSmoking with chronic pulmonary disease
CDiabetes mellitus
DChronic renal disease
4.
(C)
Which of the following is the most important transmission route of the causative pathogen in this case?
AAir-borne transmission from diseased human
BContact transmission from healthcare workers
CAerosol inhalation from water environment
DBlood transfusion or needle sharing from diseased human
5.
(D)
Which of the following is not a poor prognostic factor of pneumonia in this case?
AElderly (>65 years)
BSeptic shock with acute renal failure
CMultiple lobar pneumonia with hypoxia
DNumerous PMNs (50-75/LPF) in the sputum specimens
6.
(B)
Which of the following antimicrobial agents is not active for the causative pathogen in this case?
A Erythromycin
BCeftriaxone
CLevofloxacin
DDoxycycline

µª®×¸Ñ»¡
    1. ( C ) ¥»¯f±w¬°ÄY­«ªÀ°Ï©ÊªÍª¢¡A¯f±w¦³°®«y¡B©I§l§xÃø¡B¸z­G¯gª¬(¸¡µh©M¸¡Âm)¡B·NÃѤ£²Mµ¥«D¨å«¬ªÍª¢¤§Á{§Éªí²{¡A¥t¥~¥»¯f±w¤§®È¹C¥v»P¤ô±µÄ²¥H¤Îªì¨B¹êÅç«ÇÀˬd(¥]¬A·ð²G­²Äõ¤ó¬V¦â¥¼¨£©úÅã­P¯f­ì¡B¥Õ¦å²y¼W¦h¡B§C¶u¦å¯g¤Î¨xµÇ¥\¯à²§±`)¥ç¬°°h¥î­x¤H¯g±`¨£¤§ÀËÅçªí²{¡C
    2. ( C )°h¥î­x¤H±ìµßÁöµM¬°­²Äõ¤ó¬V¦â³±©Ê±ìµß¡A¦ý¤£©ö¦b¤@¯ëªº¬V¦â¤¤¥i¬Ý¨ì¡F¥t¥~¡A°h¥î­x¤Hµß°ö¾i®É»Ý­n¥b¯ÖÓi»Ä¡]cysteine¡^¤Î¨ä¥LÀç¾i¯À¡A¦]¦¹»Ý¥H»Ý­n¯S®íªº°ö¾i¥×(Buffered charcoal yeast extract (BCYE) agar)°õ¦æ¡A¤@¯ëªº¦å²G°ö¾i¥×µLªk¥Íªø¡C¦å²M¤Î§¿²G¤§§Ü­ì§ÜÅéÀˬd¬O¥Ø«e³Ì±`¨Ï¥Î¨Ó½T©w°h¥î­x¤H¯g¶EÂ_ªºÀËÅç¡C
    3. (A )°h¥î­x¤H¯gµo¥Í¤§°ª¦MÀI±Ú¸s¬°¡G¦~ªøªÌ(50·³¥H¤W)¡B¦³¼ç¦bºC©Ê¯e¯f(¦p¿}§¿¯f¡BºC©Ê¤ßªÍ¯e¯f¡BµÇŦ¯f)¡B©âµÒ¡B°sÅ}¡B±µ¨ü¾¹©x²¾´Ó¤Î¨Ï¥Î§K¬Ì§í¨îÃĪ«µ¥¯f±w¡A¥¼±µ¨üªÍª¢²yµß¬Ì­]¨Ã«D¥»¯e¯f¤§¦MÀI¦]¤l¡A¥Ø«e¨ÃµL°h¥î­x¤H¯g¬Ì­]¥i¹w¨¾¡C
    4. ( C )°h¥î­x¤H±ìµß¥i¦b¦hºØªºÀô¹Ò¤¤¦s¦b¡A¤×¨ä¾A¦X¦bÄá¤ó20 ¡V 45«×ªº·Å¤ô¤¤¥Íªø¡C°h¥î­x¤Hµß¥i©óÀô¹Ò¤¤(¥]¬A¡G¤ô¤Îªd¤g)¦s¬¡¼Æ­Ó¤ë¡A¥B¯à«ùÄòºû«ù¨ä­P¯f©Ê¡F¨ä¤¤¤ôÀô¹Ò¬O°h¥î­x¤Hµß¤ÑµM¥Íªø³B¡A¤]¬O·P¬Vªº¥D­n¨Ó·½¡F¨ä¶Ç¼½³~®|«h¥H§t¦³¯f­ìµß¤§Àô¹Ò­¸ªj(droplet)ª½±µ§l¤J¬°¥D¡A¤×¨ä¸g¥Ñ¼QÃúª¬¤§¤ô®ð(aerosol)¡A¨ä¨Ó·½¥]¬A¡G§N«o¤ô¶ð¡B©I§lªvÀø¾¹±ñ¡B²O¯Dµ¥¡C°h¥î­x¤H¯g¨Ã¤£·|³z¹L¤H»P¤H¤§¶¡ªº±µÄ²¦Ó¶Ç¼½¡C
    5. ( D )°h¥î­x¤H¯g¯f¤H¤§ªÍª¢¯gª¬»P¶i®i®t²§·¥¤j¡A±q»´·L«y¹Â¡Bµo¿N¦Ü©I§l°IºÜ¡B¦h¾¹©x°IºÜµ¥¬Ò¦³¥i¯à¡C®Ú¾Ú¬ã¨sÅã¥Ü¡G¦~ÄÖ¶V¤j¡B¦³ÄY­«ºC©Ê¨t²Î©Ê¯e¯f(¿}§¿¯f¡BºC©ÊªÍ³¡¯e¯f¡BµÇŦ¯f¡B´c©Ê¸~½F¡B±µ¨ü§K¬Ì§í¨î¾¯ªvÀø©Î¾¹©x²¾´Ó)¡Bªì´Á¯f±¡¶VÄY­«¡]¦p¯Ê®ñ¡B¥ð§J¡B¦hµo©ÊªÍ¸­®û¼í¡^µ¥¬Ò¬O¹w«á¤£¨}¤§¦MÀI¦]¤l¡C¦Ó·ð²G¤¤¥Õ¦å²y¼Æ¥Ø»P¯e¯fÄY­««×¨ÃµLª½±µÃö«Y¡C
    6. ( B )±`¥ÎªvÀø°h¥î­x¤H¯gÃĪ«¥]¬A¡G¬õÅð¯ÀÃþ(macrolides¦perythromycin)¡B(¤f«¶)¿Õà¬Ãþ(fluoroquinolones¦plevofloxacin)¡B¥|ÀôÅð¯ÀÃþ(tetracyclines¦pdoxycycline)¡BÁDÓiÃþ(trimethoprim/sulfamethoxazole)µ¥¡C¦Ó½L¥§¦èªLÃþ(penicillins)¤ÎÀYÌU¤l¯ÀÃþ(cephalosporins)¹ï°h¥î­x¤Hµß·P¬V¨ÃµLªvÀø®ÄªG¡C


Top of Page